Abstract
AbstractClinically approved anti-coagulant Fondaparinux is safe since it has zero contamination problems often associated with animal based heparins. Fondaparinux is a synthetic pentasaccharide based on the antithrombin-binding domain of Heparin sulfate and contains glucosamine, glucuronic acid and iduronic acid in its sequence. Here, we show the formal synthesis of Fondaparinux pentasaccharide by performing all glycosidations in a catalytic fashion for the first time to the best of our knowledge. Designer monosaccharides were synthesized avoiding harsh reaction conditions or reagents. Further, those were subjected to reciprocal donor-acceptor selectivity studies to guide [Au]/[Ag]-catalytic glycosidations for assembling the pentasaccharide in a highly convergent [3 + 2] or [3 + 1 + 1] manner. Catalytic and mild activation during glycosidations that produce desired glycosides exclusively, scalable route to the synthesis of unnatural and expensive iduronic acid, minimal number of steps and facile purifications, shared use of functionalized building blocks and excellent process efficiency are the salient features.
Funder
DST | Science and Engineering Research Board
Publisher
Springer Science and Business Media LLC
Subject
Materials Chemistry,Biochemistry,Environmental Chemistry,General Chemistry
Reference45 articles.
1. Linhardt, R. J. Heparin: structure and activity. J. Med. Chem. 46, 2551–2564 (2003).
2. Linhardt, R. J. In Carbohydrates as Drugs. (eds. Witczak, Z., Nieforth, K.) (Dekker, New York) 277–341 (1998).
3. Walenga, J. M. et al. Development of a synthetic heparin pentasaccharide: fondaparinux. Turk. J. Haematol. 19, 137–150 (2002).
4. Mueller, R. L. & Scheidt, S. History of drugs for thrombotic disease. Discovery, development, and directions for the future. Circulation 89, 432–449 (1994).
5. Petitou, M., Casu, B. & Lindahl, U. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochemie 85, 83–89 (2003).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献